Tradestie Institutional Equity Comparison Engine
HHS vs CRESY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRESY Overall Edge
CRESY Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cresud SA (CRESY) driven by superior Growth & Margin, Options & Structure while HHS counters with relative strength in Valuation, Momentum & Technical. Fundamentally, HHS trades at 14.3x Forward P/E with -3.2% operating margin (-1.7% YoY revenue) versus CRESY at 56.6x Forward P/E and 19.3% operating margin (+20.4% YoY). In options structure, HHS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CRESY sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
HHS
HHS 14.3x vs CRESY 56.6x Fwd P/E
Growth & Margin Winner
CRESY
Op Margin -3.2% vs 19.3% ยท YoY -1.7% vs +20.4%
Momentum & Technical Winner
HHS
1Y +9.1% vs -20.3% ยท 52W Pos 69% vs 8%
Options & Structure Winner
CRESY
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
HHS
US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.85
-3.99% 1D
Market Cap
$29.9M
1M Return
-10.26%
1Y Return
+9.07%
Forward P/E
14.3x
Unified AI Score
61.8 / 100
BUY
Tech 76.0
Fund 61.0
Flow 50.0
Mom 54.0
CRESY
NASDAQ
Cresud SA
Real Estate
$9.17
-5.85% 1D
Market Cap
$690.8M
1M Return
-20.4%
1Y Return
-20.26%
Forward P/E
56.6x
Unified AI Score
54.6 / 100
HOLD
Tech 75.0
Fund 55.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HHS +9.07%
CRESY -20.26%
Spread: +55.35 pp (HHS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HHS TTM Op. Margin: -3.2%
CRESY TTM Op. Margin: 19.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs CRESY. Trailing 12-month operating profitability (HHS -3.2% vs CRESY 19.3%) and valuation multiples (HHS 14.3x vs CRESY 56.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HHS | CRESY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9M | $690.8M | Larger Scale | CRESY |
| Trailing P/E Ratio Valuation | 14.3x | 6.3x | Lower Multiple | CRESY |
| Forward P/E Ratio Valuation | 14.3x | 56.6x | Lower Multiple | HHS |
| Revenue Growth (YoY) Growth | -1.7% | +20.4% | Higher Growth | CRESY |
| Operating Margin (TTM) Profitability | -3.2% | 19.3% | Higher Margin | CRESY |
| Net Profit Margin Profitability | -3.7% | 9.6% | Higher Margin | CRESY |
| Return on Equity (ROE) Capital Efficiency | -30.4% | 8.6% | Higher ROE | CRESY |
| 52-Week Range Position Momentum | 69% ($2โ$5) | 8% ($9โ$14) | Stronger Trend | HHS |
| Beta / 30D Volatility Risk Regime | 0.49ฮฒ ยท 46% Vol | 0.82ฮฒ ยท 59% Vol | Lower Realized Risk | HHS |
| Unified Institutional Score Composite Signal | 61.8 / 100 (BUY) | 54.6 / 100 (HOLD) | Higher Composite | HHS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HHS vs CRESY Buy Guide
HHS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CRESY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HHS nor CRESY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.